 Connection
Yuya Hirasawa to Cholangitis, Sclerosing
This is a "connection" page, showing publications Yuya Hirasawa has written about Cholangitis, Sclerosing.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.666 |
|
|
|
-
Hirasawa Y, Yoshimura K, Matsui H, Kubota Y, Ishida H, Arai J, Sakaki M, Oguro N, Shida M, Taniguchi M, Hamada K, Ariizumi H, Ishiguro T, Ohkuma R, Sambe T, Horiike A, Imamura CK, Shiozawa E, Wada S, Tsurutani J, Iwamoto S, Uchida N, Kiuchi Y, Tate G, Kobayashi S, Tsunoda T. A case report on severe nivolumab-induced adverse events similar to primary sclerosing cholangitis refractory to immunosuppressive therapy. Medicine (Baltimore). 2021 Jun 11; 100(23):e25774.
Score: 0.666
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|